UNSPSC 51283706: Cefonicid

This classification denotes a cephalosporin antibiotic with the molecular formula C18H18N6O8S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6532B86WFG, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((hydroxyphenylacetyl)amino)-8-oxo-3-(((1-sulfomethyl)-1h-tetrazol-5-yl)thio)methyl)-, (6r-(6-alpha,7-beta(r*)))- but generally known as cefonicid, which bears US NIH Compound Identifier 43592.

UNSPSC 51283706 Cefonicid is a Commodity code that covers pharmaceutical products, specifically cefonicid (a third-generation cephalosporin antibiotic), though recent state and local solicitations tagged under this code show significant scope mismatch. The actual procurement activity does not center on cefonicid itself but instead spans a broader range of pharmaceuticals, medical supplies, and pharmacy benefit programs — including naloxone, over-the-counter products, generic multi-source pharmaceuticals, and direct-to-manufacturer prescription initiatives. State and local issuing bodies using this code include county health departments (Seminole County, Florida), city fire and rescue services (Tampa Fire Department), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota and Oregon). The solicitation types range from sealed-bid invitations for emergency medical supplies to RFIs for pharmacy benefit program design and RFPs for pharmaceutical supply agreements.

Recent opportunities span Florida, Texas, Minnesota, and Oregon. The Seminole County IFB (IFB60459723LAS, due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually for community health delivery. The City of Tampa's sealed-bid solicitation (26P00145, due March 13, 2026) sought 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a sheltered-market set-aside for certified Small Local Business Enterprises offering a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance RFP (S1070000015802, due March 26, 2026) sought generic multi-source pharmaceuticals and OTC products distributed across state and local facilities, requiring vendors to work through three authorized wholesalers and comply with cGMP and Drug Supply Chain Security Act standards. The Texas Health and Human Services Commission issued an RFI (HHS0017013, posted April 3, 2026) to gather market intelligence on direct-to-manufacturer prescription programs serving self-insured employer and government health plans. The code shows activity concentrated in emergency medical supply, community health, and institutional pharmacy contexts, though the mismatch between the nominal code name and actual solicitations suggests potential procurement-classification inconsistencies in the underlying data.